HCPCS Level II code J7202 describes an injectable recombinant Factor IX albumin fusion protein (Idelvion) supplied per international unit (1 i.u.), used for replacement therapy in patients with hemophilia B; the service is a therapeutic coagulation factor infusion typically administered in outpatient infusion centers, hospital outpatient departments, or specialty clinics.

For related coverage guidance, see recent payer policy updates: Epithelial Cell Cytology in Breast Cancer Risk Assessment, Antibody-Drug Conjugates, Chemotherapy Observation or Inpatient Hospitalization (for New Mexico Only).